DL-3-Aminoisobutyric acid

DL-3-Aminoisobutyric acid is a non-proteinogenic amino acid with a branched 3-aminoisobutyric acid skeleton, featuring a primary amino group and a carboxylic acid that can be converted into protected derivatives for controlled peptide chemistry. The compound exists as a DL mixture, providing racemic stereochemistry around the chiral center, which is useful for building stereochemical libraries or for downstream resolution strategies. Branched aliphatic substitution influences coupling behavior and side-chain sterics, while the amino and acid functionalities enable formation of amide bonds, salt formation, and esterification to tune solubility and reactivity. As a chiral amino acid intermediate precursor, it can be transformed into N-protected amino acid derivatives and activated carboxyl species compatible with peptide coupling and synthetic organic chemistry workflows.

1. Peptide Synthesis

DL-3-Aminoisobutyric acid is applied in peptide synthesis as a branched aliphatic amino acid building block for incorporating non-standard residues into peptide sequences and peptidomimetic scaffolds. The amino and carboxyl groups can be protected and activated to support amide bond formation, while the steric profile of the 3-aminoisobutyric side chain can modulate conformational preferences and coupling outcomes. Racemic stereochemistry enables preparation of mixed stereochemical peptide analogs for structure-activity relationship studies, or it can serve as a starting point for stereoselective resolution to access enantiopure derivatives. Downstream, the resulting protected or coupled peptide fragments can be used for generating peptide libraries, reference standards, and synthetic intermediates in amino acid chemistry.

2. Amino Acid Derivatization

DL-3-Aminoisobutyric acid is utilized for amino acid derivatization workflows that generate N-protected amino acid derivatives, carboxyl-activated intermediates, and solubility-tuned esters for chemical manufacturing and fine chemical synthesis. The primary amine supports N-protection strategies such as carbamate or sulfonamide formation, enabling chemoselective peptide coupling and controlled deprotection sequences. The carboxylic acid can be converted into acid chlorides, activated esters, or coupling-ready species to facilitate downstream transformation into amide-linked products and labeled or functionalized analogs. Racemic availability can also be leveraged to create derivatized mixtures for screening, followed by stereochemical refinement when enantiopure material is required.

3. Chiral Building Block Development

DL-3-Aminoisobutyric acid is suitable for chiral building block development in process chemistry intermediate preparation, where racemic material is used to access enantiopure targets through resolution or asymmetric conversion routes. The stereogenic center in the amino acid backbone makes it a practical feedstock for producing chiral amino acid intermediates that can be carried through N-protected amino acid synthesis and subsequent peptide coupling chemistry. N-protection and carboxyl activation strategies help maintain stereochemical integrity during fragment assembly and minimize side reactions from the free amino and acid functionalities. Downstream products include enantiopure protected amino acids and stereodefined peptide fragments used in molecular design, stereochemical SAR studies, and synthetic methodology development.

4. Chemical Biology Probes

DL-3-Aminoisobutyric acid can be employed in chemical biology research to construct amino acid-based probes and peptide analogs that incorporate non-proteinogenic residues for modulating recognition and stability. The branched aliphatic side chain and the ability to form amide linkages support incorporation into peptide-like structures that can be conjugated to tags, handles, or linkers after N- and C-functional group management. Carboxyl activation and N-protection strategies enable controlled attachment points for downstream bioconjugation chemistry, including formation of stable amide-linked conjugates. Racemic starting material may be used to generate mixed stereochemical probe sets for assay development, while enantiopure derivatives can be pursued when stereochemical effects on binding or processing are evaluated.

5. Pharmaceutical Intermediate Preparation

DL-3-Aminoisobutyric acid is relevant to pharmaceutical intermediate preparation and specialty chemical production where non-proteinogenic amino acid fragments are required for synthetic routes to peptide-like active ingredients or process intermediates. The amino acid functional groups support conversion into protected amino acid derivatives and coupling-ready intermediates used in stepwise assembly of amide-rich structures. Branched side-chain sterics can influence crystallization behavior, salt formation, and impurity profiles during manufacturing, making controlled protection and activation strategies important for robust process design. Racemic feedstock can also serve as a starting point for stereochemically defined downstream synthesis, aligning with industrial fine chemical synthesis practices for chiral intermediate generation.

1. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

2. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

5. Myotropic activity of allatostatins in tenebrionid beetles